SCHEMBL30689408

SCHEMBL30689408

C=C(Cc1nc(-c2ccc(Oc3cccc(C(=O)NC)n3)cc2)no1)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 4/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ACACB O00763 1/20 0.38
▸ MAPT P10636 6/20 0.37
▸ LMNA P02545 3/20 0.36
▸ ATM Q13315 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ SMPD1 P17405 1/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ PPARA Q07869 1/20 0.35
▸ BTK Q06187 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689383 0.88 TP53 (0.41) TP53ACACBMAPTLMNAATM
SCHEMBL30689348 0.83 IP6K1 (0.41) TP53ACACBLMNAATMALDH1A1
SCHEMBL30689338 0.78 ACACB (0.36) TP53NPC1CYP1A2CYP2C9CYP2C19
SCHEMBL30689312 0.78 FPR2 (0.43) MAPTTSHRSMN1; SMN2SCN9A
SCHEMBL25802137 0.77 MAPT (0.50) MAPTLMNAALDH1A1TSHRSMN1; SMN2
SCHEMBL25807565 0.76 TP53 (0.42) TP53NPC1CYP1A2CYP2C9CYP2C19
SCHEMBL25802125 0.76 MEN1 (0.46) TP53NPC1CYP1A2CYP2C9CYP2C19
SCHEMBL25802130 0.76 TP53 (0.42) TP53NPC1CYP1A2CYP2C9CYP2C19
SCHEMBL25801756 0.76 TSHR (0.55) NPC1CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL23588077 0.76 ACACB (0.52) TP53NPC1ACACBMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback